Skip to main content

Table 5 Bivariate analysis of enterococci infections at the UoGTH, February 28, 2014 to May 1, 2014

From: Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital

Characteristics Total
No. (%)
Enterococci infection COR (95% CI) P- value
Presence
No. (%)
Absence
No. (%)
Total 385 (100%) 24 (6.2%) 361 (93.8%)   
Sex
 Female 176 10 (5.7) 166 (94.3) 1.19 (0.51–2.75) 0.68
 Male 209 14 (6.7) 195 (93.3) 1.00  
Age      0.06
 <5 123 12 (9.8) 111 (90.2) 0.26 (0.03–2.10) 0.21
 5–14 36 1 (2.8) 35 (97.2) 0.26 (0.07–0.96) 0.04
 15–30 108 3 (2.8) 105 (97.2) 0.35 (0.10–1.27) 0.11
 31–50 83 3 (3.6) 80 (96.4) 1.54 (0.50–4.72) 0.45
 >50 35 5 (14.3) 30 (85.7) 1.00  
Hospital stay (hours)
 <48 353 7 (2) 346 (98) 1.00  
 ≥48 32 17 (53) 15 (47) 56.02 (18.32–178.39) 0.00
HIV
 Negative 367 22 (6) 345 (94) 1.00  
 Positive 18 2 (0.1) 16 (99.9) 1.96 (0.00–9.79) 0.39
CD4 counta
 <200 6 0 (0.0) 6 (100) 0.00 (0.00–9.76)  
 >200 12 2 (16.7) 10 (83.3) 1.00 0.52
HAARTa
 Pre 9 2 (22.2) 7 (87.8) 1.00  
 On 9 0 (0.0) 9 (100) 0.00 (0.00–4.38) 0.47
WHO stagea      1.00
 I 5 2 (40) 3 (60) 1.00  
 II 1 0 (0.0) 1 (100) 0.00 (0.00–60.98) 1.00
 III 6 0 (0.0) 6 (100) 0.00 (0.00–3.71) 0.18
 IV 6 0 (0.0) 6 (100) 0.00 (0.00–3.71) 0.18
History of:
 Animal contact 111 10 (9) 101 (90) 1.84 (0.73–4.58) 0.15
 Antibiotics usage 54 14 (25.9) 40 (74.1) 11.24 (4.34–29.47) 0.00
 Cancer 3 1 (33.3) 2 (66.7) 7.80 (0.00–116.25) 0.18
 Catheterization 17 11 (64.7) 6 (35.3) 50.06 (14.24–184.31) 0.00
 Diabetics 9 0 (0.0) 9 (100) 0.00 (0.00–9.28) 1.00
 Cotrimoxazole prophylaxisa 36 2 (5.6) 34 (94.4) 0.87 (0.20 - 3.88) 1.00
 Hospitalization 40 11 (27.5) 29 (72.5) 9.69 (3.66–25.68) 0.00
 Immunosuppressive usage 51 3 (5.9) 48 (94.1) 0.93 (0.21–3.47) 1.00
 Laboratory confirmed Bacterial infection 10 3 (30) 7 (70) 7.22 (1.36–34.43) 0.02
 Prosthetic device usage 10 1 (10) 9 (90) 1.70 (0.21–14.01) 0.48
 Surgery 6 0 (0.0) 6 (100) 0.00 (0.00–14.88) 1.00
 UTI 55 2 (3.6) 53 (96.4) 0.53 (0.08–2.42) 0.55
  1. aOnly for HIV positives